Sickle cell disease and pregnancy profile of complicated malaria in 982 pregnancies in Kinshasa
- PMID: 36201515
- PMCID: PMC9536558
- DOI: 10.1371/journal.pone.0275115
Sickle cell disease and pregnancy profile of complicated malaria in 982 pregnancies in Kinshasa
Abstract
Introduction: Malaria is associated with high morbidity during pregnancy. Homozygous sickle cell pregnant women are even more exposed during complicated malaria. The objective of the study was to evaluate the maternal and fetal morbidity of homozygous sickle cell pregnant pregnant women with complicated malaria.
Methods: We conducted a retrospective case-control study of 982 pregnancies in sickle cell pregnant women, during which a group of sickle cell pregnant women who received antimalarial chemoprophylaxis was compared to another group without chemoprophylaxis. We analyzed the clinical evolution of pregnant women (VOCs and transfusions, pregnancy weight gain) and parasite (parasite density at the time of diagnosis of complicated malaria and during treatment for three days). We analyzed the parameters of newborns at birth (age of pregnancy at the time of delivery, birth weight, weight of the placenta and histopathological examination of the placenta.
Results: Out of 982 pregnancies, 15% of pregnant women suffered from complicated malaria, 57% suffered from uncomplicated malaria and 28% did not suffer from malaria. Pregnancy weight gain, birth weight, was better in the group of pregnant women who received chemoprophylaxis and the placenta had less histological lesions. Parasite density was low. There was a significant positive correlation between parasite density and the number of CVOs and transfusions and between parasite density and histological lesions of the placenta and low birth weight.
Conclusion: Complicated malaria is associated with high maternal and fetal morbidity in sickle cell patients. Malaria chemoprophylaxis can reduce maternal and fetal complications and parasite density during malaria infection.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Randomised trial of alternative malaria chemoprophylaxis strategies among pregnant women in Kigoma, Tanzania: II. Results from baseline studies.East Afr Med J. 2000 Feb;77(2):105-10. doi: 10.4314/eamj.v77i2.46410. East Afr Med J. 2000. PMID: 10774084 Clinical Trial.
-
An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.Ann Trop Med Parasitol. 1998 Mar;92(2):141-50. doi: 10.1080/00034989859979. Ann Trop Med Parasitol. 1998. PMID: 9625909
-
Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.Am J Trop Med Hyg. 1996;55(1 Suppl):24-32. doi: 10.4269/ajtmh.1996.55.24. Am J Trop Med Hyg. 1996. PMID: 8702034 Clinical Trial.
-
[Malaria during pregnancy: consequences and interventional perspectives].Med Trop (Mars). 2003;63(4-5):369-80. Med Trop (Mars). 2003. PMID: 14763291 Review. French.
-
An overview of malaria in pregnancy.Semin Perinatol. 2019 Aug;43(5):282-290. doi: 10.1053/j.semperi.2019.03.018. Epub 2019 Mar 16. Semin Perinatol. 2019. PMID: 30979598 Free PMC article. Review.
Cited by
-
Sickle cell anemia and pregnancy: Profile of hemodynamic changes in sickle cell pregnant women in Kinshasa.EJHaem. 2023 Sep 11;4(4):977-983. doi: 10.1002/jha2.789. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024611 Free PMC article.
References
-
- World health Organization. Severe Falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94 (suppl 1):1–90. PubMed | Google Scholar. - PubMed
-
- WHO. World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO; 2020.
-
- World Malaria Report 2021, Key Messages, WHO/UCN/GMP/2021.08.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical